GET REAL: A Guide to Evolving Treatment of nAMD and DME Using Real-World Data
Arshad M. Khanani, MD, MA
Theodore Leng, MD, MS
Extending Treatment Durability With Next-Generation Neovascular AMD Therapies
Durga Borkar, MD, MMCi
Diana V. Do, MD
Peter K. Kaiser, MD
Improving Outcomes in Patients with RVO: Tailoring Treatment
Carl Danzig, MD
A Closer Look at Real-World Strategies for Treatment-Resistant DME
Christina Y. Weng, MD, MBA, FASRS
A Look at the Numbers: Cost of Durable Treatments in Retinal Disease
Jayanth Sridhar, MD
Sabin Dang, MD
Real-World Treatment of Retinal Disease
Reconsidering the Algorithm: Treatment-Resistant DME
Reconsidering the Algorithm: nAMD
Impacts on Access to Eye Care: Key Socioeconomic Factors
Mario R. Nacinovich, Jr., MSc
Sally L. Baxter, MD, MSc
Social Media: A Friend or Foe for Healthcare Professionals?
Hector O. Chapa, MD, FACOG
Mikaela Rush, MD FACOG
Concerns in the Community: Obstacles to Accessing the COVID-19 Vaccine
Robert Owens Carpenter, MD, MPH, FACS, FASMBS
Toni E. Keaton, MD, MPH
Discovering Disparities in Diversity: Representation in Clinical Trials
Jennifer Caudle, DO
Narjust Duma, MD
Caretaking Amid COVID-19: Strategies for Patient Protection
Jennifer Shu, MD, FAAP
Explore the World with a Career in Locum Tenens
Dalilah Restrepo, MD
Julia A. Haller, MD
Mark T. Dunbar, OD, FAAO
Loading...
We’re glad to see you’re enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.